國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Drug delivery challenges and novel t...

Cioffi, Christopher L.

Drug delivery challenges and novel therapeutic approaches for retinal diseases

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug delivery challenges and novel therapeutic approaches for retinal diseasesedited by Christopher L. Cioffi.
其他題名:	a
其他作者:	Cioffi, Christopher L.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	ix, 272 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	RetinaDiseases
電子資源:	https://doi.org/10.1007/978-3-030-56619-7
ISBN:	9783030566197$q(electronic bk.)

Drug delivery challenges and novel therapeutic approaches for retinal diseases
Drug delivery challenges and novel therapeutic approaches for retinal diseases[electronic resource] /aedited by Christopher L. Cioffi. - Cham :Springer International Publishing :2020. - ix, 272 p. :ill., digital ;24 cm. - Topics in medicinal chemistry,351862-2461 ;. - Topics in medicinal chemistry ;8..

An Overview of Retinal Diseases and Current Ocular Drug Discovery -- Ocular Pharmacokinetics and Drug Delivery Challenges -- Models of Pathologies Associated with Age-related Macular Degeneration and Their Utilities in Drug Discovery -- Recent Developments in Agents for the Treatment of Age-Related Macular Degeneration and Stargardt Disease -- Targets and Strategies toward the Development of Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema -- Recent Developments for the Treatment of Glaucoma -- Emerging Gene Therapy Treatments for Retinal Degenerative Diseases.

This book reviews the current state of ocular drug therapy and future therapeutic opportunities for a wide variety of conditions, including Age-related Macular Degeneration, Diabetic Retinopathy and Macular Edema, Glaucoma, and Inherited Retinal Diseases. Retinal diseases are major contributors to moderate or severe vision impairment in adults aged 50 years and older. The respective patient populations for many of these indications is expected to significantly increase as the world population continues to grow older. An improved understanding of the etiological underpinnings of ocular degenerative diseases over the past decade has significantly bolstered ophthalmic drug discovery. In this volume, contributions from leading experts explore the unique challenges faced for ocular drug discovery and delivery providing the reader with detailed information on ocular pharmacokinetics, in vitro, ex vivo and in vivo models for retinal disease pathology and emerging gene therapy treatments. The book is intended for all researchers and clinicians who wish to increase their knowledge on the latest findings in ocular drug therapy.

ISBN: 9783030566197$q(electronic bk.)

Standard No.: 10.1007/978-3-030-56619-7doiSubjects--Topical Terms:

787120
Retina
--Diseases

LC Class. No.: RE551

Dewey Class. No.: 617.735

Drug delivery challenges and novel therapeutic approaches for retinal diseases
LDR:02811nmm a2200349 a 4500 001 585864
003 DE-He213
005 20201231160949.0
006 m d
007 cr nn 008maaau
008 210323s2020 sz s 0 eng d
020 $a 9783030566197$q(electronic bk.)
020 $a 9783030566180$q(paper)
024 7 $a 10.1007/978-3-030-56619-7 $2 doi
035 $a 978-3-030-56619-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RE551
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 617.735 $2 23
090 $a RE551 $b .D794 2020
245 0 0 $a Drug delivery challenges and novel therapeutic approaches for retinal diseases $h [electronic resource] / $c edited by Christopher L. Cioffi.
246 3 $a a
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a ix, 272 p. : $b ill., digital ; $c 24 cm.
490 1 $a Topics in medicinal chemistry, $x 1862-2461 ; $v 35
505 0 $a An Overview of Retinal Diseases and Current Ocular Drug Discovery -- Ocular Pharmacokinetics and Drug Delivery Challenges -- Models of Pathologies Associated with Age-related Macular Degeneration and Their Utilities in Drug Discovery -- Recent Developments in Agents for the Treatment of Age-Related Macular Degeneration and Stargardt Disease -- Targets and Strategies toward the Development of Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema -- Recent Developments for the Treatment of Glaucoma -- Emerging Gene Therapy Treatments for Retinal Degenerative Diseases.
520 $a This book reviews the current state of ocular drug therapy and future therapeutic opportunities for a wide variety of conditions, including Age-related Macular Degeneration, Diabetic Retinopathy and Macular Edema, Glaucoma, and Inherited Retinal Diseases. Retinal diseases are major contributors to moderate or severe vision impairment in adults aged 50 years and older. The respective patient populations for many of these indications is expected to significantly increase as the world population continues to grow older. An improved understanding of the etiological underpinnings of ocular degenerative diseases over the past decade has significantly bolstered ophthalmic drug discovery. In this volume, contributions from leading experts explore the unique challenges faced for ocular drug discovery and delivery providing the reader with detailed information on ocular pharmacokinetics, in vitro, ex vivo and in vivo models for retinal disease pathology and emerging gene therapy treatments. The book is intended for all researchers and clinicians who wish to increase their knowledge on the latest findings in ocular drug therapy.
650 0 $a Retina $x Diseases $x Treatment. $3 787120
650 0 $a Pharmaceutical chemistry. $3 203135
650 0 $a Drug delivery systems. $3 196465
650 0 $a Ophthalmology. $3 274149
650 0 $a Pharmaceutical technology. $3 237657
650 0 $a Gene therapy. $3 189024
650 1 4 $a Medicinal Chemistry. $3 275183
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Gene Therapy. $3 196467
700 1 $a Cioffi, Christopher L. $3 877129
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Topics in medicinal chemistry ; $v 8. $3 567153
856 4 0 $u https://doi.org/10.1007/978-3-030-56619-7
950 $a Chemistry and Materials Science (SpringerNature-11644)